Unlocking the Brain’s Resilience With Dr. Nora D. Volkow

As Director of the National Institute on Drug Abuse (NIDA), Dr. Nora D. Volkow is leading research to unlock the brain’s resilience with cutting-edge advancements in addiction research and science to enhance our understanding of substance use disorders (SUDs). For example, NIDA research involving innovative tools to study brain function, gene expression, and complex behaviors holds promise to improve models used in SUD treatment. And by identifying socioenvironmental factors such as discrimination and economic hardship as prevention targets, NIDA’s work helps clinicians address underlying issues in patients’ lives, offering new tools to support patients in recovery.

Psychiatric-mental health nurses will have the chance to hear directly from this globally recognized leader at the APNA 23rd Annual Clinical Psychopharmacology Institute (CPI) this June 5-8, 2025 in Rockville, Maryland, or via livestream.

“Nora’s work has had some of the most profound influence on my practice over the years! Her research on brain development and its impact on decision-making and impulse control is truly excellent. Her most impactful work lies in SUDs being a disease of the brain and how the brain heals throughout the recovery process.”

– Laura Leahy, CPI Committee Member

As an attendee at CPI, you’ll take a glimpse into future therapies, the transformative power of comprehensive treatment, and so much more. See the other great minds booked to speak at CPI, and join them on a journey through the latest in brain science, addiction, recovery, and so many more topics!